Table 4.
Self-reported medication side effects of patients (N = 423)* according to treatment type
| FGA1 | SGA2 | |||
| men | women | men | women | |
| Parkinson symptoms | 17% | 15.6% | 3.8% | 11.6% |
| dyskinetic/dystonic symptoms | 35.8% | 31.3% | 9.4% | 9.7% |
| akathisia | 22.6% | 12.5% | 6% | 6.8% |
| hyperprolactinaemia | - | - | - | 1.9% |
| hormonal dysfunctions (gynecomastia, absence/changes of menorrhea) | - | 9.4% | - | 5.8% |
| sexual dysfunction | 7.5% | - | 10.3% | - |
| vertigo (incl. hypotonia) | 5.7% | 12.5% | 5.1% | 8.7% |
| weight gain | 9.4% | 18.7% | 38.3% | 39.8% |
| diabetes mellitus | - | - | 0.4% | - |
| sialorrhea ('drooling') | - | - | 20.4% | 6.8% |
| skin abnormalities, loss of hair | 1.9% | - | 1.7% | 5.8% |
| gastrointestinal symptoms | 1.9% | 6.3% | 5.9% | 7.8% |
| hyperhidrosis | - | - | 2.6% | - |
| psychological symptoms (loss of concentration, no drive, tiredness) | 33.9% | 28.1% | 44.2% | 31.1% |
| cardiovascular symptoms (tachycardia, hypertension) | - | - | 1.3% | 1.9% |
| impaired vision | - | - | 1.7% | 3.9% |
| dry mouth | 5.7% | 9.4% | 5.1% | 4.9% |
| urinary retention | - | 3.1% | 1.3% | - |
| number of patients who reported side effects | 53 | 32 | 235 | 103 |
1FGA - first generation antipsychotics, typical antipsychotics
2SGA - second generation antipsychotics, atypical antipsychotics
*Only N = 423 patients (out of 1012 patients who were on antipsychotic medication) reported side effects (see text for details).